Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CLDX

Celldex Therapeutics, Inc.

CIK 0000744218 · Nasdaq

NasdaqHealth CareIn Vitro & In Vivo Diagnostic Substances
$38.98
↑ 0.02 (0.05%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$3.06B
P/E Ratio
-10.79
EPS
-3.90
Dividend Yield
Not covered
52W Position
94%
Beta
1.49

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
6.71
P/S
3,537.13
EV/Revenue
3,495.83
ROE
-62.2%
Valuation data covers 8,500/9,463 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 94%
$19.72$40.30

Latest Financials

2025-12-31 FY
Revenue
$1.54M
Net Income
-$258.76M
Total Assets
$582.98M
Free Cash Flow
-$213.66M

Recent news